Royal Bank of Canada Issues Positive Forecast for WELL Health Technologies (TSE:WELL) Stock Price

WELL Health Technologies (TSE:WELL) had its price objective raised by Royal Bank of Canada from C$7.00 to C$8.50 in a research note issued to investors on Tuesday morning,BayStreet.CA reports.

WELL has been the subject of a number of other research reports. Ventum Financial lowered their target price on WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating for the company in a research note on Tuesday, October 29th. Haywood Securities lifted their price objective on shares of WELL Health Technologies from C$8.00 to C$10.00 in a research note on Friday, December 13th. CIBC upped their target price on shares of WELL Health Technologies from C$5.25 to C$7.00 in a research note on Friday, December 13th. Scotiabank lifted their price target on shares of WELL Health Technologies from C$6.00 to C$7.00 in a research note on Monday, December 16th. Finally, TD Securities upped their price objective on shares of WELL Health Technologies from C$8.00 to C$8.50 in a research report on Tuesday, December 17th.

WELL Health Technologies Price Performance

WELL Health Technologies stock opened at C$7.26 on Tuesday. The company has a quick ratio of 1.02, a current ratio of 1.25 and a debt-to-equity ratio of 41.57. The firm has a market capitalization of C$1.81 billion, a P/E ratio of 12.74, a PEG ratio of -1.93 and a beta of 1.20. The firm has a fifty day moving average of C$5.99 and a 200-day moving average of C$5.05. WELL Health Technologies has a 52-week low of C$3.41 and a 52-week high of C$7.36.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.